卫生部-话题@MedSci - williamhill asia

#卫生部#

100篇内容 | 1875人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1443366, encodeId=75bc144336663, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=美国卫生部长30天内两次感染新冠！有美国人曾重复五次感染, objectType=article, longId=729638, objectId=944be29638de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=944be29638de, replyNumber=0, likeNumber=65, createdTime=2022-06-17, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=944be29638de, moduleTitle=美国卫生部长30天内两次感染新冠！有美国人曾重复五次感染, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=944be29638de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443365, encodeId=c197144336583, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=新加坡卫生部长王乙康：抗疫过程中的决策都是以科学为基础, objectType=article, longId=724778, objectId=4982e24778eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4982e24778eb, replyNumber=0, likeNumber=56, createdTime=2022-04-23, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4982e24778eb, moduleTitle=新加坡卫生部长王乙康：抗疫过程中的决策都是以科学为基础, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4982e24778eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443364, encodeId=696314433641f, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=美国卫生部：ONC《2022版互操作标准建议》, objectType=article, longId=294674, objectId=ff8b2946e409, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8b2946e409, replyNumber=0, likeNumber=60, createdTime=2022-01-27, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8b2946e409, moduleTitle=美国卫生部：ONC《2022版互操作标准建议》, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ff8b2946e409)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443363, encodeId=224b1443363a0, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人, objectType=article, longId=210385, objectId=e5f921038592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5f921038592, replyNumber=0, likeNumber=59, createdTime=2021-04-25, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5f921038592, moduleTitle=中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e5f921038592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443362, encodeId=3960144336230, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, objectType=article, longId=201927, objectId=300020192e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=300020192e1c, replyNumber=0, likeNumber=0, createdTime=2020-10-12, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=300020192e1c, moduleTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=300020192e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443361, encodeId=c6dd14433612c, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=马晓伟主任出席二十国集团财政和卫生部长视频会议, objectType=article, longId=200922, objectId=ca8a2009227c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca8a2009227c, replyNumber=0, likeNumber=53, createdTime=2020-09-20, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca8a2009227c, moduleTitle=马晓伟主任出席二十国集团财政和卫生部长视频会议, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ca8a2009227c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443360, encodeId=ec0a14433604e, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=德国确诊超25万将投入40亿欧元增强卫生部门抗疫能力, objectType=article, longId=200367, objectId=533f20036e00, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=533f20036e00, replyNumber=0, likeNumber=68, createdTime=2020-09-08, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=533f20036e00, moduleTitle=德国确诊超25万将投入40亿欧元增强卫生部门抗疫能力, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=533f20036e00)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, objectType=article, longId=194148, objectId=4528194148c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4528194148c3, replyNumber=0, likeNumber=0, createdTime=2020-05-16, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4528194148c3, moduleTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4528194148c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443358, encodeId=5d651443358f9, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, objectType=article, longId=193904, objectId=7e121939040f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e121939040f, replyNumber=0, likeNumber=64, createdTime=2020-05-12, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e121939040f, moduleTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7e121939040f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443357, encodeId=b25c144335ed8, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=俄卫生部长：目前谈论俄疫情平台期为时过早, objectType=article, longId=193636, objectId=da821936367c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da821936367c, replyNumber=0, likeNumber=65, createdTime=2020-05-08, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da821936367c, moduleTitle=俄卫生部长：目前谈论俄疫情平台期为时过早, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=da821936367c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443356, encodeId=99e214433560a, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=美首例新冠患者用伦地西韦有效，药企称正与中国卫生部门合作, objectType=article, longId=187125, objectId=649618e125df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649618e125df, replyNumber=0, likeNumber=66, createdTime=2020-02-03, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649618e125df, moduleTitle=美首例新冠患者用伦地西韦有效，药企称正与中国卫生部门合作, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=649618e125df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443355, encodeId=ea6714433555b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准卡那列净的新适应症，以降低2型糖尿病患者肾病相关风险, objectType=article, longId=186986, objectId=f35818698644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f35818698644, replyNumber=0, likeNumber=52, createdTime=2020-01-31, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f35818698644, moduleTitle=加拿大卫生部批准卡那列净的新适应症，以降低2型糖尿病患者肾病相关风险, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f35818698644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443354, encodeId=6dc114433540b, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准Drax Exametazime用于核医学成像, objectType=article, longId=186911, objectId=42d8186911ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42d8186911ac, replyNumber=0, likeNumber=48, createdTime=2020-01-30, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42d8186911ac, moduleTitle=加拿大卫生部批准Drax Exametazime用于核医学成像, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=42d8186911ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443353, encodeId=613314433532c, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, objectType=article, longId=183715, objectId=fe2f183e1514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2f183e1514, replyNumber=0, likeNumber=68, createdTime=2019-11-29, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2f183e1514, moduleTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=fe2f183e1514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443352, encodeId=7ab41443352c2, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准DARZALEX与来那度胺和地塞米松联合用于不适合移植的初治多发性骨髓瘤患者, objectType=article, longId=182203, objectId=0a4818220319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a4818220319, replyNumber=0, likeNumber=64, createdTime=2019-11-02, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a4818220319, moduleTitle=加拿大卫生部批准DARZALEX与来那度胺和地塞米松联合用于不适合移植的初治多发性骨髓瘤患者, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=0a4818220319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443351, encodeId=8739144335128, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法, objectType=article, longId=177619, objectId=7d301e761945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d301e761945, replyNumber=0, likeNumber=0, createdTime=2019-08-16, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d301e761945, moduleTitle=加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7d301e761945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443350, encodeId=d0d21443350d3, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤, objectType=article, longId=176548, objectId=f7e11e654865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7e11e654865, replyNumber=0, likeNumber=65, createdTime=2019-08-01, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7e11e654865, moduleTitle=加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f7e11e654865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443349, encodeId=e7ea1443349e3, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=西安一医院6岁女童输液管里现毛发类异物，卫生部门介入调查, objectType=article, longId=168055, objectId=bc12168055fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc12168055fe, replyNumber=0, likeNumber=54, createdTime=2019-06-12, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc12168055fe, moduleTitle=西安一医院6岁女童输液管里现毛发类异物，卫生部门介入调查, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=bc12168055fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443348, encodeId=70ea14433481a, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=加拿大卫生部批准**款曲妥珠单抗生物仿制药Ogivri用于治疗HER2阳性的乳腺癌和胃癌, objectType=article, longId=166718, objectId=55b4166e1844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b4166e1844, replyNumber=0, likeNumber=114, createdTime=2019-05-25, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b4166e1844, moduleTitle=加拿大卫生部批准**款曲妥珠单抗生物仿制药Ogivri用于治疗HER2阳性的乳腺癌和胃癌, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=55b4166e1844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443347, encodeId=240f144334e24, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, objectTitle=日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用, objectType=article, longId=166313, objectId=6efb166313f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6efb166313f3, replyNumber=0, likeNumber=65, createdTime=2019-05-20, rootId=0, userName=12498e67m29暂无昵称, userId=538e5060306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6efb166313f3, moduleTitle=日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6efb166313f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

卫生部

2020-05-29

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

美国卫生部长30天内两次感染新冠！有美国人曾重复五次感染

2022-06-17

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

新加坡卫生部长王乙康：抗疫过程中的决策都是以科学为基础

2022-04-23

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

美国卫生部：ONC《2022版互操作标准建议》

2022-01-27

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

中国工程院2021年院士增选577位有效候选人名单公布，其中医药卫生部84位有效候选人

2021-04-25

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请

2020-10-12

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

马晓伟主任出席二十国集团财政和卫生部长视频会议

2020-09-20

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

德国确诊超25万将投入40亿欧元增强卫生部门抗疫能力

2020-09-08

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准首例新冠病毒抗体的血清学测试

2020-05-16

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床

2020-05-12

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

俄卫生部长：目前谈论俄疫情平台期为时过早

2020-05-08

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

美首例新冠患者用伦地西韦有效，药企称正与中国卫生部门合作

2020-02-03

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准卡那列净的新适应症，以降低2型糖尿病患者肾病相关风险

2020-01-31

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准Drax Exametazime用于核医学成像

2020-01-30

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降

2019-11-29

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准DARZALEX与来那度胺和地塞米松联合用于不适合移植的初治多发性骨髓瘤患者

2019-11-02

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法

2019-08-16

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准VITRAKVI®（larotrectinib）治疗NTRK基因融合的晚期实体瘤

2019-08-01

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

西安一医院6岁女童输液管里现毛发类异物，卫生部门介入调查

2019-06-12

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

加拿大卫生部批准**款曲妥珠单抗生物仿制药Ogivri用于治疗HER2阳性的乳腺癌和胃癌

2019-05-25

12498e67m29暂无昵称 (审核中...)

前往app查看评论内容

#卫生部#

日本卫生部发出警告，乳腺癌药物Verzenio可能对肺部产生严重的副作用

2019-05-20

科室
- - 订阅+
  - 更多科室
工具
服务